Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adial Pharmaceuticals (ADIL) Current Assets (2022 - 2024)

Adial Pharmaceuticals' Current Assets history spans 3 years, with the latest figure at $1.7 million for Q3 2024.

  • For Q3 2024, Current Assets rose 219.77% year-over-year to $1.7 million; the TTM value through Sep 2024 reached $1.7 million, up 219.77%, while the annual FY2023 figure was $3.2 million, 33.08% down from the prior year.
  • Current Assets for Q3 2024 was $1.7 million at Adial Pharmaceuticals, up from $1.4 million in the prior quarter.
  • Across five years, Current Assets topped out at $13.0 million in Q1 2022 and bottomed at $524318.0 in Q3 2023.
  • The 3-year median for Current Assets is $3.0 million (2023), against an average of $4.3 million.
  • The largest annual shift saw Current Assets crashed 92.26% in 2023 before it soared 219.77% in 2024.
  • A 3-year view of Current Assets shows it stood at $4.8 million in 2022, then crashed by 33.08% to $3.2 million in 2023, then crashed by 47.58% to $1.7 million in 2024.
  • Per Business Quant, the three most recent readings for ADIL's Current Assets are $1.7 million (Q3 2024), $1.4 million (Q2 2024), and $590226.0 (Q1 2024).